Related Experiment Video
Updated: Aug 27, 2025

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model
Published on: October 11, 2022
Akt: a key transducer in cancer
Pei-Jane Tsai1,2,3, Yi-Hsin Lai3, Rajesh Kumar Manne1
1Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA.
Abstract:
Growth factor signaling plays a pivotal role in diverse biological functions, such as cell growth, apoptosis, senescence, and migration and its deregulation has been linked to various human diseases. Akt kinase is a central player transmitting extracellular clues to various cellular compartments, in turn executing these biological processes. Since the discovery of Akt three decades ago, the tremendous progress towards identifying its upstream regulators and downstream effectors and its roles in cancer has been made, offering novel paradigms and therapeutic strategies for targeting human diseases and cancers with deregulated Akt activation. Unraveling the molecular mechanisms for Akt signaling networks paves the way for developing selective inhibitors targeting Akt and its signaling regulation for the management of human diseases including cancer.
Insights
Growth factor signaling, crucial for cell functions, is regulated by Akt kinase. Understanding Akt signaling pathways offers new therapeutic strategies for diseases like cancer with deregulated Akt activation.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- Growth factor signaling regulates fundamental cellular processes like growth, apoptosis, senescence, and migration.
- Deregulation of these pathways is implicated in various human diseases, notably cancer.
- Akt kinase acts as a central mediator in transmitting extracellular signals to cellular components.
Purpose of the Study:
- To review the progress in understanding Akt signaling pathways.
- To highlight the role of Akt in cancer and other human diseases.
- To emphasize the potential of targeting Akt for therapeutic interventions.
Main Methods:
- Literature review of Akt signaling research over the past three decades.
- Analysis of upstream regulators and downstream effectors of Akt.
- Examination of Akt's role in cancer pathogenesis.
Main Results:
- Significant advancements have been made in identifying Akt's regulators and effectors.
- Akt signaling is frequently deregulated in various cancers, presenting therapeutic targets.
- Targeting Akt and its regulatory networks offers promising strategies for disease management.
Conclusions:
- Elucidating Akt signaling mechanisms is key to developing targeted therapies.
- Selective Akt inhibitors hold potential for treating cancers and other diseases with aberrant Akt activation.
- Continued research into Akt pathways will drive novel therapeutic paradigms.
More Related Videos
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
12:24Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012